Biology Reference
In-Depth Information
[33] Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D. MHC class I deficiency: susceptibility to
natural killer (NK) cells and impaired NK activity. Science 1991;253(5016):199-202.
[34] Lowin-Kropf B, Kunz B, Beermann F, Held W. Impaired natural killing of MHC class
I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1. J
Immunol 2000;165(3):1314-21.
[35] Barao I, Alvarez M, Ames E, Orr MT, Stefanski HE, Blazar BR, et al. Mouse Ly49G2+
NK cells dominate early responses during both immune reconstitution and activation
independently of MHC. Blood 2011;117(26):7032-41.
[36] Joncker NT, Fernandez NC, Treiner E, Vivier E, Raulet DH. NK cell responsiveness is
tuned commensurate with the number of inhibitory receptors for self-MHC class I: the
rheostat model. J Immunol 2009;182(8):4572-80.
[37] Brodin P, Lakshmikanth T, Johansson S, Karre K, Hoglund P. The strength of inhibitory
input during education quantitatively tunes the functional responsiveness of individual
natural killer cells. Blood 2009;113(11):2434-41.
[38] O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent
adaptive immunity mediated by natural killer cells. Nat Immunol 2006;7(5):507-16.
[39] Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature
2009;457(7229):557-61.
[40] Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM. Cytokine-induced
memory-like natural killer cells. Proc Natl Acad Sci U S A 2009;106(6):1915-9.
[41] Lopez-Verges S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, et al. Expansion
of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalo-
virus infection. Proc Natl Acad Sci U S A 2011;108(36):14725-32.
[42] Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, et al. Cytomegalovirus
reactivation after allogeneic transplantation promotes a lasting increase in educated
NKG2C+ natural killer cells with potent function. Blood 2012;119(11):2665-74.
[43] Guma M, Budt M, Saez A, Brckalo T, Hengel H, Angulo A, et al. Expansion of CD94/
NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood
2006;107(9):3624-31.
[44] Bjorkstrom NK, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M, et al. Rapid
expansion and long-term persistence of elevated NK cell numbers in humans infected
with hantavirus. J Exp Med 2011;208(1):13-21.
[45] Petitdemange C, Becquart P, Wauquier N, Beziat V, Debre P, Leroy EM, et al. Unconven-
tional repertoire profile is imprinted during acute chikungunya infection for natural
killer cells polarization toward cytotoxicity. PLoS Pathog 2011;7(9):e1002268.
[46] Hayakawa Y, Huntington ND, Nutt SL, Smyth MJ. Functional subsets of mouse natural
killer cells. Immunol Rev 2006;214:47-55.
[47] Hallett WH, Murphy WJ. Positive and negative regulation of natural killer cells: thera-
peutic implications. Semin Cancer Biol 2006;16(5):367-82.
[48] Cooper MA, Bush JE, Fehniger TA, VanDeusen JB, Waite RE, Liu Y, et al. In vivo evi-
dence for a dependence on interleukin 15 for survival of natural killer cells. Blood
2002;100(10):3633-8.
[49] Sun JC, Ma A, Lanier LL. Cutting edge: IL-15-independent NK cell response to mouse
cytomegalovirus infection. J Immunol 2009;183(5):2911-4.
[50] Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, et al. Suppression of
graft-versus-host disease and amplification of graft-versus-tumor effects by acti-
vated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest
1998;101(9):1835-42.
[51] Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effective-
ness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
Science 2002;295(5562):2097-100.
[52] Hu B, He Y, Wu Y, Bao G, Liu H, Welniak LA, et al. Activated allogeneic NK
cells as suppressors of alloreactive responses. Biol Blood Marrow Transplant
2010;16(6):772-81.
[53] Koh CY, Blazar BR, George T, Welniak LA, Capitini CM, Raziuddin A, et al. Augmenta-
tion of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo.
Blood 2001;97(10):3132-7.
[54] Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, et al. NKG2D-deficient mice
are defective in tumor surveillance in models of spontaneous malignancy. Immunity
2008;28(4):571-80.
[55] Iguchi-Manaka A, Kai H, Yamashita Y, Shibata K, Tahara-Hanaoka S, Honda S,
et al. Accelerated tumor growth in mice deficient in DNAM-1 receptor. J Exp Med
2008;205(13):2959-64.
[56] Barber MA, Zhang T, Gagne BA, Sentman CL. NK cells negatively regulate antigen
presentation and tumor-specific CTLs in a syngeneic lymphoma model. J Immunol
2007;178(10):6140-7.
352
Search WWH ::
Custom Search